险峰K2VC
Beijingk2vc.com
Overview
险峰K2VC (K2VC), founded in 2010, is an early-stage venture capital firm that focuses on investments in technology, business model innovation, and consumer lifestyle. The firm manages several RMB and USD funds and has invested in over 700 startups. It operates two main investment arms: K2 Angel Partners (险峰长青), which focuses on industrial angel investments, and K2 Bio Partners (险峰淇云), which specializes in life sciences and healthcare.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Moffett AI | May 2026 | Series C | Co-investor |
| YolTech Therapeutics | May 2026 | Series C | Co-investor |
| Sanegene Bio | Dec 2025 | Series B | Co-investor |
| Cornerstone Robotics | Jan 2025 | Series C | Co-investor |
| Viewtrix Technology | Sep 2024 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
